HBP-08

N/A

Report date: 2023/05/22 18:08:27
NME

Base Information

Drug NameHBP-08
Drug Alias NameHBP-08
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionCXCL12 and HMGB1 interaction inhibitor
TargetsC-X-C motif chemokine ligand 12High Mobility Group Protein B1
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversità della Svizzera italiana
China Registration ClassN/A

Develop Information

Active CompaniesUniversità della Svizzera italiana
Inactive CompaniesN/A
Active IndicationsInflammation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A